Pulmonx Corp (LUNG): Capital Expenditures
$452.0K
Year ended 2025-12-31
$112.0K
Trailing 12 months to 2026-06-30
-30.0%
3-year compound annual growth
-13.1%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $452.0K | -68.8% | 2026-03-10, From 2025-01-01 |
| 2024-12-31 | $1.45M | +79.3% | 2026-03-10, From 2024-01-01 |
| 2023-12-31 | $807.0K | -38.8% | 2025-02-25, From 2023-01-01 |
| 2022-12-31 | $1.32M | -64.1% | 2024-02-27, From 2022-01-01 |
| 2021-12-31 | $3.67M | +303.0% | 2023-03-01, From 2021-01-01 |
| 2020-12-31 | $911.0K | +26.5% | 2022-03-01, From 2020-01-01 |
| 2019-12-31 | $720.0K | +127.8% | 2021-03-15, From 2019-01-01 |
| 2018-12-31 | $316.0K | n/a | 2021-03-15, From 2018-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Pulmonx Corp (LUNG) | 2025-12-31 | $452.0K | -68.8% |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | $34.89M | +52.1% |
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $1.55M | +176.7% |
| Iradimed Corp (IRMD) | 2025-12-31 | $7.76M | -3.0% |
| NeuroPace Inc (NPCE) | 2025-12-31 | $332.0K | +8.5% |
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $5.30M | +56.0% |
| TELA Bio, Inc. (TELA) | 2025-12-31 | $448.0K | -54.7% |
| PRO DEX Inc (PDEX) | 2026-06-30 | $483.0K | -61.2% |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $224.0K | -41.8% |
Compare LUNG, KMTS, DCTH, IRMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗